The National Health Service England confirmed Tuesday that starting this week, doctors can prescribe Jazz Pharmaceuticals JAZZ Epidiolex, a CBD-based medicine, to patients suffering from tuberous ...
Please provide your email address to receive an email when new articles are posted on . Survey responses reflected positive language and communication outcomes after cannabidiol use. Further ...
Survey on tuberous sclerosis complex finds fragmented care, lack of information, scarcity of support
Tuberous sclerosis complex (TSC) is a rare genetic disease (approximate 1:6,000 birth incidence) with a wide variability of physical and neuropsychiatric symptoms. Patients require lifelong care from ...
Tuberous sclerosis complex (TSC) is a rare genetic condition that causes non-cancerous (benign) tumors in various organs of the body, including in the brain. It is also accompanied by patches of ...
The Tuberous Sclerosis Complex (TSC) Fellowship at UAB provides an opportunity for pediatric and adult neurologists with an interest in TSC clinical research and patient care to develop specialized ...
A team of researchers led by UCL Great Ormond Street Institute of Child Health (ICH) and Great Ormond Street Hospital (GOSH) has found that metformin - a drug commonly used to treat Type 2 diabetes - ...
RADNOR, Pa.--(BUSINESS WIRE)--Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced ...
RADNOR, Pa.--(BUSINESS WIRE)--Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced ...
The Company plans to discontinue further clinical development of ganaxolone in TSC. Marinus Pharmaceuticals announced that its phase 3 trial of ganaxolone did not meet the primary end point for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results